With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.50982-12-2,Dichloro(cycloocta-1,5-diene)ruthenium(II),as a common compound, the synthetic route is as follows.
1,2-closo-C2B10H12 (0.400 g, 2.77 mmol) was dissolved in degassed THF (35 mL). Na metal (0.300 g, 13.04 mmol) and naphthalene (ca. 15 mg) were added and the solution stirred overnight. The resulting dark green solution was transferred via a gas-tight syringe into a second Schlenk tube containing [RuCl2(COD)]x (0.650 g, 2.32 mmol) and a large excess of naphthalene. The resulting brown mixture was heated at reflux for 90 min then allowed to cool to room temperature. The brown mixture was filtered through a short silica column eluting with DCM to afford a brown solution, removal of solvent from which yielded a brown solid. This was further purified by column chromatography (1:2 DCM:40-60 petroleum ether), giving a yellow band, followed by preparative TLC (4:3 DCM:40-60 petroleum ether, Rf 0.55) yielding, as major product C12H20B10Ru requires C 38.59, H 5.40. Found: C 38.01, H 5.67%.
As the paragraph descriping shows that 50982-12-2 is playing an increasingly important role.
Reference£º
Article; Scott, Greig; Ellis, David; Rosair, Georgina M.; Welch, Alan J.; Journal of Organometallic Chemistry; vol. 721-722; (2012); p. 78 – 84;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI